A team of researchers from Chalmers University of Technology in Sweden and the Polish Wroclaw University of Technology have created a new technique with multi-photon lasers that could attack clumps of amyloid protein plaques, which are the hallmark of Alzheimer’s disease, reported Smithsonian.com on Nov. 8.

A new method for predicting time to full-time care, nursing home residence, or death for patients with Alzheimer’s disease has been validated by a Columbia University Medical Center (CUMC) research team, as reported by the CUMC Newsroom on Nov. 7.

Cocaine addiction can ruin a person physically and financially, and with an estimated 1.4 million cocaine users in the U.S., thousands will become trapped by their habit. While previous research on the drug and its addictive potential were observational and subjective, imaging is reshaping how we see addiction—and how it will be treated.

A team from the U.K. government’s Medical Research Council has developed a drug that prevents neurons from being destroyed due to the abnormal proteins that lead to Alzheimer’s disease and other degenerative brain diseases, according to a report from Sky News.

As neuroimaging technology continues to be researched as a tool for early diagnosis of Alzheimer’s disease, researchers at the University of Florida (UF), Gainesville, have been investigating a much more low-tech alternative requiring only a ruler and a dab of peanut butter.

Every dog owner has wondered what goes through the mind of their pet, but the answer to this question has proven elusive. However, thanks to MRI scans and some well-trained test subjects, researchers are beginning to understand just how complex dog emotions can be.

According to the Alzheimer's Disease International 2013 World Alzheimer's Report, "Journey of Caring," care associated with Alzheimer's disease and other forms of dementia is a global issue that must be addressed as prevalence and costs continue to soar, placing enormous stress on families and nations alike.

A new drug to treat Alzheimer’s disease would obviously impact the lives of millions of people in the U.S. affected by the disease. Any significant breakthrough could also mean tens of billions of dollars for the pharmaceutical company that makes it.